Enobia develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.
Goldman, Sachs & Co. acted as financial advisor to Alexion.
Ropes and Gray LLP acted as lead legal counsel to Alexion and Cassels Brock & Blackwell LLP acted as Canadian legal counsel to Alexion.